Molecular Therapy — Oncolytics · 2019 · 19 citations · 36 references
Life SciencesCancer BiologyOncologyApoptosisMolecular VirologyVirologyCancer ImmunotherapyOncogenic VirusesOncolytic Virus TherapyViral InfectionsViral PathogenesisImmune Evasion By Oncogenic VirusesOncolytic Viral TherapyOncolytic Viral VectorsOncolytic Virus EngineeringTumor ResistanceVesicular Stomatitis Virus VectorsViral Engineering
Despite reports of successful clinical cases, many tumors appear to resist infection by oncolytic viruses (OVs). To circumvent this problem, an armed vesicular stomatitis virus was constructed by inserting a transgene to express Smac/DIABLO during virus infection (VSV-S). Endogenous Smac in HeLa cells was diminished during wtVSV infection, whereas the Smac level was enhanced during VSV-S infection. Apoptosis was readily induced by VSV-S, but not wtVSV, infection. More importantly, the tumor volume was reduced to a larger extent when xenografts of 4T1 cells in BALB/c mice and OV-resistant T-47D cells in nude mice were intratumorally injected with VSV-S. VSV-S represents a novel mechanism to overcome tumor resistance, resulting in more significant tumor regression due to enhanced apoptosis.
36
Breast Tumor Cell Lines From Pleural Effusions2
Relda Cailleau, Russell K. Young, Matilde Olivé et al. · JNCI Journal of the National Cancer Institute · 1974 · 1K citations · Full text
Binlei Liu, Max Robinson, Z-Q Han et al. · Gene Therapy · 2003 · 792 citations
Medicine, Cancer Biology, Oncology +10